Product Program year 2025 Source: CMS Open Payments

Elecsys Troponin T Gen 5 STAT

Device Centralized Diagnostics

PDI 04015630942695

Open in the dashboard

General payments

$32,646

66 payments

Research payments

$2,571,453

54 payments

Through program year 2025, $32,646 in general payments and $2,571,453 in research payments were reported against Elecsys Troponin T Gen 5 STAT (Centralized Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2025 General $255 7
2025 Research $681,475 5
2024 General $13,114 34
2024 Research $39,403 4
2023 General $122 2
2023 Research $92,178 6
2022 General $3,282 5
2022 Research $911,894 21
2021 General $15,874 18
2021 Research $846,504 18

Breakdown

Who paid General payments · program years 2021–2025
  1. Roche Diagnostics Corporation $32,646 66 payments
Top recipients General payments · program year 2025
  1. Ambarish Pandey Cardiovascular Disease · Dallas, TX $98 38% · 1 payment
  2. David Weisman Neurology · Abington, PA $27 10% · 1 payment
  3. Syed Athar Interventional Cardiology · Loma Linda, CA $26 10% · 1 payment
  4. Heather Rojas Anatomic Pathology & Clinical Pathology · Loma Linda, CA $26 10% · 1 payment
  5. Andre Nguyen Surgery · Loma Linda, CA $26 10% · 1 payment

The top 5 of 7 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Cardiovascular Disease Internal Medicine $98 38% · 1 practitioner
  2. Neurology Psychiatry & Neurology $27 10% · 1 practitioner
  3. Interventional Cardiology Internal Medicine $26 10% · 1 practitioner
  4. Surgery $26 10% · 1 practitioner
  5. Clinical Nurse Specialist, Neuroscience Clinical Nurse Specialist $26 10% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $130 51% · 5 recipients
  2. Texas $98 38% · 1 recipient
  3. Pennsylvania $27 10% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

66 general · 54 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record